Company profile
Siloton Limited
We utilise the power of integrated photonics to tackle some of the greatest challenges in eye imaging and optical coherence tomography.
Financial period: 1 May 2024 to 30 Apr 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUxNDc2MTUyN2FkaXF6a2N4
Published 07 Apr 2026 13:53
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzMzEyMDkyNGFkaXF6a2N4
Published 22 Aug 2024 15:22
Company registered at Companies House
1 May 2024 to 30 Apr 2025
Age-related macular degeneration (AMD) is the leading cause of sight loss in the developed world. It affects 1 in 4 over 60s. Patients with the wet form of the disease (wetAMD) can receive anti-VEGF injections to slow progression, however this requires regular monitoring of their condition through optical coherence tomography (OCT) eye scans. OCT systems ...
1 Jun 2022 to 31 Jan 2023
65% of over 60's suffer with a condition called age-related macular degeneration (AMD). This is a degenerative disease impacting an area at the back of your eye. AMD is the leading cause of blindness in the developed world. As populations age, this patient group will apply substantial pressure to health systems that are already struggling to keep up with ...
